Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ECYT | RXRX | SLNO | ||
| Company | Endocyte Inc | Recursion Pharmaceuticals Inc Cl A | Soleno Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.99 | 6.16 | 45.01 | ||
| High | 24.00 | 7.01 | 45.37 | ||
| Low | 23.99 | 6.10 | 44.05 | ||
| Last | 23.99 | 6.99 | 44.94 | ||
| Change | -0.01 | +0.96 | -0.24 | ||
| % Change | -0.04% | +15.92% | -0.52% | ||
| Volume | 2,340,200 | 20,889,100 | 479,600 | ||
| 20-Day Average Volume | 2,218,100 | 16,876,176 | 782,850 | ||
| Previous Close | 24.00 | 6.03 | 45.18 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.77 | 6.94 | 49.32 | ||
| 20-Day Raw Stochastic | 98.36% | 31.18% | 9.23% | ||
| 20-Day Relative Strength | 68.37% | 51.21% | 35.88% | ||
| Weighted Alpha | +177.90 | -36.77 | +4.30 | ||
| Today's Opinion | N/A | Hold | 24% Sell | ||
| Previous Opinion | N/A | 48% Sell | 24% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.54% since 12/13/18 | -6.05% since 12/16/24 | -6.23% since 12/16/24 | ||
| Low | 23.84 on 12/14/18 | 5.93 on 12/20/24 | 43.32 on 12/19/24 | ||
| High | 24.00 on 12/20/18 | 7.47 on 12/17/24 | 48.51 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +1.78% since 11/20/18 | +22.63% since 11/22/24 | -22.21% since 11/22/24 | ||
| Low | 23.39 on 11/28/18 | 5.83 on 11/26/24 | 43.32 on 12/19/24 | ||
| High | 24.00 on 12/20/18 | 9.55 on 12/09/24 | 60.92 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +36.07% since 09/20/18 | +4.80% since 09/23/24 | -6.64% since 09/23/24 | ||
| Low | 14.50 on 10/11/18 | 5.60 on 11/22/24 | 43.32 on 12/19/24 | ||
| High | 24.00 on 12/20/18 | 9.55 on 12/09/24 | 60.92 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +63.87% since 06/20/18 | -21.02% since 06/21/24 | +9.22% since 06/21/24 | ||
| Low | 12.76 on 06/22/18 | 5.60 on 11/22/24 | 36.93 on 06/26/24 | ||
| High | 24.00 on 12/20/18 | 9.86 on 06/25/24 | 60.92 on 11/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,969,339 | 2,003,621 | 1,937,894 | ||
| Shares Outstanding, K | 82,090 | 286,641 | 43,117 | ||
| Annual Sales | 70,000 | 44,580,000 | 0 | ||
| Annual Net Income | -55,060,000 | -328,070,000 | -38,990,000 | ||
| Last Quarter Sales | 90,000 | 26,080,000 | 0 | ||
| Last Quarter Net Income | -12,610,000 | -95,840,000 | -76,620,000 | ||
| 60-Month Beta | -0.01 | 0.85 | -1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 02/26/18 | -0.34 on 11/06/24 | -1.83 on 11/06/24 | ||
| Latest Earnings Date | 11/05/18 | 11/06/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||